MedPath
NMPA Approval

Fluticasone Furoate Nasal Spray

国药准字HJ20170104

November 2, 2021

H20170104

Drug Information

糠酸氟替卡松鼻用喷雾剂

文适

喷雾剂

每喷含糠酸氟替卡松27.5μg

化学药品

November 2, 2021

November 1, 2026

Company Information

Applicant Company

12 Riverwalk,Citywest Business Campus,Dublin 24, Ireland

Manufacturing Company

glaxo operations uk ltd (trading as glaxo wellcome operations)

Harmire Road, Barnard Castle, County Durham, DL12 8DT, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

糠酸氟替卡松鼻用喷雾剂 - NMPA 批准文号 | MedPath